Detalles de la búsqueda
1.
Cetuximab and Irinotecan With or Without Bevacizumab in Refractory Metastatic Colorectal Cancer: BOND-3, an ACCRU Network Randomized Clinical Trial.
Oncologist
; 27(4): 292-298, 2022 04 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35380713
2.
Behavioral and health outcomes from the NRG Oncology/NSABP B-36 trial comparing two different adjuvant therapy regimens for early-stage node-negative breast cancer.
Breast Cancer Res Treat
; 192(1): 153-161, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35112166
3.
Phase II, Multicenter, Randomized Trial of Docetaxel plus Prednisone with or Without Cediranib in Men with Chemotherapy-Naive Metastatic Castrate-Resistant Prostate Cancer.
Oncologist
; 24(9): 1149-e807, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31152080
4.
E4206: AMG 706 and Octreotide in Patients with Low-Grade Neuroendocrine Tumors.
Oncologist
; 23(9): 1006-e104, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29853660
5.
A phase II study to evaluate LY2603618 in combination with gemcitabine in pancreatic cancer patients.
BMC Cancer
; 17(1): 137, 2017 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28202004
6.
Erlotinib, cabozantinib, or erlotinib plus cabozantinib as second-line or third-line treatment of patients with EGFR wild-type advanced non-small-cell lung cancer (ECOG-ACRIN 1512): a randomised, controlled, open-label, multicentre, phase 2 trial.
Lancet Oncol
; 17(12): 1661-1671, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27825638
7.
"Enjoy glass of wine before eating:" a randomized trial to test the orexigenic effects of this advice in advanced cancer patients.
Support Care Cancer
; 24(9): 3739-46, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27039205
8.
A phase 2 cooperative group adjuvant trial using a biomarker-based decision algorithm in patients with stage I non-small cell lung cancer (SWOG-0720, NCT00792701).
Cancer
; 120(15): 2343-51, 2014 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24752945
9.
Blood-based tumor mutational burden as a biomarker for atezolizumab in non-small cell lung cancer: the phase 2 B-F1RST trial.
Nat Med
; 28(5): 939-945, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35422531
10.
Exploring therapeutic decisions in elderly patients with non-small cell lung cancer: results and conclusions from North Central Cancer Treatment Group Study N0222.
Cancer Invest
; 29(4): 266-71, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21345074
11.
A phase III randomized, double-blind, placebo-controlled study of pilocarpine for vaginal dryness: North Central Cancer Treatment group study N04CA.
J Support Oncol
; 9(3): 105-12, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21702402
12.
The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial.
Support Care Cancer
; 19(11): 1769-77, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-20936417
13.
DeImplementing Ineffective and Low-Value Clinical Practices: Research and Practice Opportunities in Community Oncology Settings.
JNCI Cancer Spectr
; 5(2)2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33860151
14.
SWOG S1400A (NCT02154490): A Phase II Study of Durvalumab for Patients With Previously Treated Stage IV or Recurrent Squamous Cell Lung Cancer (Lung-MAP Sub-study).
Clin Lung Cancer
; 22(3): 178-186, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33358401
15.
Neratinib-Plus-Cetuximab in Quadruple-WT (KRAS, NRAS, BRAF, PIK3CA) Metastatic Colorectal Cancer Resistant to Cetuximab or Panitumumab: NSABP FC-7, A Phase Ib Study.
Clin Cancer Res
; 27(6): 1612-1622, 2021 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33203645
16.
Impact of Diabetes and Insulin Use on Prognosis in Patients With Resected Pancreatic Cancer: An Ancillary Analysis of NRG Oncology RTOG 9704.
Int J Radiat Oncol Biol Phys
; 109(1): 201-211, 2021 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32858111
17.
Use of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Initial Results From the Pembrolizumab Arm of a Phase 2 Randomized Clinical Trial.
JAMA Oncol
; 7(8): 1225-1230, 2021 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34196693
18.
Gabapentin for the management of hot flashes in prostate cancer survivors: a longitudinal continuation Study-NCCTG Trial N00CB.
J Support Oncol
; 8(3): 128-32, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20552926
19.
Dual VEGF inhibition with sorafenib and bevacizumab as salvage therapy in metastatic colorectal cancer: results of the phase II North Central Cancer Treatment Group study N054C (Alliance).
Ther Adv Med Oncol
; 12: 1758835920910913, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32201506
20.
SWOG S1400B (NCT02785913), a Phase II Study of GDC-0032 (Taselisib) for Previously Treated PI3K-Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub-Study).
J Thorac Oncol
; 14(10): 1839-1846, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31158500